Clinical characteristics and treatment management of combined large cell neuroendocrine carcinoma, a subtype of large cell neuroendocrine carcinoma.

导出 LinkOut

翻译打印收藏纠错

第一作者： Kai,Kang

第一单位： Thoracic Surgery, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.

作者： Kai,Kang ^[1] ; Binfeng,Li ^[1] ; Sheng,Wang ^[1] ; Jianjian,Wang ^[1] ; Xinjun,Liang ^[2]

作者单位： Thoracic Surgery, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. ^[1] Department of Abdominal Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. ^[2]

关键词 LCNEC RB1 and TP53 co-mutation adjuvant chemotherapy combined large cell neuroendocrine carcinoma molecular typing

DOI 10.3389/fonc.2024.1449490

PMID 39502318

发布时间 2024-11-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交